Study analyzes effect of music therapy on palliative care patients

Music therapy can enhance terminally ill patients' wellbeing and relaxation. This treatment has been known since the 1970s, but there is little scientific research on the subject. A recent randomized controlled trial by Marco Warth et al. in Deutsches Ärzteblatt International (Dtsch Arztebl Int 2015; 112: 788-94) analyzes the effect of music therapy on palliative care patients.

The trial recruited 84 patients in palliative care: one group received passive music therapy with breathing exercises and vocal improvisation. These were accompanied by a monochord, a specially developed wooden instrument with an atmospheric, overtone-rich sound. The other patients, in the control group, underwent a relaxation program instead of music therapy. Participants were asked about their level of relaxation and their wellbeing before and after their sessions. These values improved more in patients who underwent music therapy than in the control group. As the authors highlight, this trial is therefore the first to provide evidence of the efficacy of receptive music therapy. The relaxation exercises used in the trial can be used by music therapists to treat palliative care patients.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research explores how omega-3 and omega-6 fatty acids may impact cancer rates